Caci International INC /DE/ Form 4 insider transactions

NYSE
CACI International Director Philip O. Nolan acquired 83 shares of common stock on October 12, 2025, through the scheduled vesting of Restricted Stock Units.
NYSE
CACI International Director Stanton D. Sloane exercised 83 Restricted Stock Units, converting them into common stock and increasing his direct beneficial ownership to 859 shares.
NYSE
CACI International Director Debora A. Plunkett acquired 83 shares of common stock through the vesting of Restricted Stock Units.
NYSE
CACI International Director Ryan D. McCarthy acquired 83 shares of common stock through the scheduled vesting of Restricted Stock Units.
NYSE
CACI International Director Scott C. Morrison converted 83 Restricted Stock Units into common stock, completing the vesting of a 331-unit grant.
NYSE
CACI International Director William L. Jews acquired 83 common shares through the vesting of Restricted Stock Units, increasing his direct beneficial ownership.
NYSE
CACI International Director Charles L. Szews reported the vesting of 83 Restricted Stock Units into common stock, completing a 331-unit grant.
NYSE
CACI Director Lisa Disbrow acquired 83 shares of common stock through the vesting of Restricted Stock Units, increasing her direct beneficial ownership to 1,934 shares.
NYSE
CACI International Director Susan M. Gordon acquired 83 shares of common stock through the vesting of Restricted Stock Units, increasing her direct beneficial ownership to 2,737 shares.
NYSE
CACI International's Chief Financial Officer, Jeffrey D. MacLauchlan, reported the vesting of restricted stock units and new equity grants on October 1, 2025.
NYSE
CACI International CEO John S. Mengucci reported the future vesting and acquisition of common stock, along with new RSU and PRSU grants, effective October 1, 2025.
NYSE
CACI International's President of US Operations, DeEtte Gray, reported multiple stock acquisitions through vesting and dispositions for tax withholding purposes.
NYSE
CACI International Inc's Chief Executive Officer, UK, Tracy Weir, reported routine stock acquisitions and dispositions related to equity compensation vesting.
NYSE
CACI International's EVP and General Counsel, J. William Koegel Jr., reported the vesting of restricted stock units and new equity grants on October 1, 2025.
NYSE
CACI International's SVP, Corporate Controller & CAO, Eric Blazer, reported recent equity transactions including RSU and PRSU grants, and common stock activity.
NYSE
CACI International's President and CEO, John S. Mengucci, sold 10,175 shares of common stock for approximately $5 million as part of a pre-arranged 10b5-1 trading plan.
NYSE
Tracy Weir, CACI International's Chief Executive Officer for the UK, converted 268 restricted stock units into common stock following their vesting on August 22, 2025.
NYSE
CACI International Director Scott C. Morrison reported the vesting of 83 Restricted Stock Units into common stock, part of a larger grant from October 2024.
NYSE
CACI International Inc. Director Susan M. Gordon reported the conversion of 83 Restricted Stock Units into common stock on July 14, 2025, as part of a pre-scheduled vesting plan.
NYSE
CACI International Inc. Director Philip O. Nolan acquired 83 shares of common stock on July 14, 2025, through the vesting of Restricted Stock Units as part of a pre-arranged 10b5-1 plan.
NYSE
CACI International Director Stanton D. Sloane converted 83 Restricted Stock Units into common stock on July 14, 2025, as part of a pre-scheduled vesting.
NYSE
CACI International Inc. Director Lisa S. Disbrow reported the acquisition of 83 shares of common stock through the vesting of Restricted Stock Units, increasing her direct beneficial ownership to 1,851 shares.
NYSE
CACI International Inc. Director Charles L. Szews reported the scheduled vesting of 83 Restricted Stock Units into common stock on July 14, 2025.
NYSE
CACI International Director Ryan McCarthy converted 83 Restricted Stock Units into common stock on July 14, 2025, increasing his direct beneficial ownership to 1,986 shares.
NYSE
CACI International Inc. Director William L. Jews reported the vesting and conversion of 83 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 6,301 shares.
NYSE
CACI International Inc. Director Debora A. Plunkett reported the vesting of 83 Restricted Stock Units and the acquisition of 83 shares of common stock on July 14, 2025, as part of a pre-scheduled vesting plan.
NYSE
Director William L. Jews of CACI International Inc. reports selling 1,036 shares of common stock on May 16, 2025.
NYSE
CACI International's CFO, Jeffrey MacLauchlan, reports the vesting and disposal of restricted stock units.
NYSE
J. William Koegel Jr., EVP and General Counsel of CACI International, reports the vesting and subsequent disposal of restricted stock units.
NYSE
Michael A. Daniels, a director at CACI International, reports acquiring 66 shares of common stock on April 17, 2025, related to his annual retainer as Chairman of the Board.